David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGLT
3251
DELISTED
Egalet Corporation
EGLT
| $211K | ﹤0.01% |
+165,056
| New | +$221K |
|
3252
Destination XL Group
DXLG
$32.2M
| $210K | ﹤0.01% |
110,435
-21,322
| -16% | -$40.8K |
|
3253
BRC Group Holdings
RILY
$287M
| $210K | ﹤0.01% |
+12,318
| New | +$214K |
|
|
EPE
3254
DELISTED
EP Energy Corporation
EPE
| $209K | ﹤0.01% |
64,019
+49,782
| +350% | +$162K |
|
|
GPT
3255
DELISTED
Gramercy Property Trust
GPT
| $209K | ﹤0.01% |
6,909
| – | – |
|
|
SNAK
3256
DELISTED
Inventure Foods, Inc.
SNAK
| $209K | ﹤0.01% |
44,669
+9,074
| +25% | +$34.4K |
|
|
CALL
3257
DELISTED
magicJack VocalTec Ltd
CALL
| $208K | ﹤0.01% |
29,065
-5,014
| -15% | -$36.7K |
|
|
AMRN
3258
Amarin Corp
AMRN
$296M
| $207K | ﹤0.01% |
2,962
+1,521
| +106% | +$108K |
|
3259
CareTrust REIT
CTRE
$9.43B
| $207K | ﹤0.01% |
+10,846
| New | +$203K |
|
3260
STAG Industrial
STAG
$7.1B
| $207K | ﹤0.01% |
+7,534
| New | +$208K |
|
|
LN
3261
DELISTED
LINE Corporation
LN
| $207K | ﹤0.01% |
+5,719
| New | +$201K |
|
|
WBC
3262
PUT
DELISTED
WABCO HOLDINGS INC.
WBC
| $207K | ﹤0.01% |
+1,400
| New | +$194K |
|
3263
PUT
Credicorp
BAP
$29.9B
| $205K | ﹤0.01% |
+1,000
| New | +$196K |
|
3264
Cohen & Steers
CNS
$4.27B
| $205K | ﹤0.01% |
+5,201
| New | +$206K |
|
|
ELLI
3265
CALL
DELISTED
Ellie Mae Inc
ELLI
| $205K | ﹤0.01% |
+2,500
| New | +$229K |
|
|
ELLI
3266
PUT
DELISTED
Ellie Mae Inc
ELLI
| $205K | ﹤0.01% |
+2,500
| New | +$229K |
|
3267
Upbound Group
UPBD
$1.12B
| $204K | ﹤0.01% |
17,752
-19,774
| -53% | -$244K |
|
3268
MillerKnoll
MLKN
$1.59B
| $203K | ﹤0.01% |
5,654
-8,166
| -59% | -$275K |
|
|
CRZO
3269
CALL
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $202K | ﹤0.01% |
11,800
+400
| +4% | +$5.84K |
|
3270
Dorian LPG
LPG
$2.21B
| $201K | ﹤0.01% |
29,529
-60,766
| -67% | -$448K |
|
3271
PUT
Globant
GLOB
$1.72B
| $200K | ﹤0.01% |
+5,000
| New | +$206K |
|
3272
NVE Corp
NVEC
$522M
| $200K | ﹤0.01% |
+2,537
| New | +$193K |
|
|
AIFU
3273
AIFU Inc
AIFU
$120M
| $198K | ﹤0.01% |
+39
| New | +$148K |
|
|
PGH
3274
DELISTED
Pengrowth Energy Corporation
PGH
| $197K | ﹤0.01% |
193,600
-4,000
| -2% | -$2.88K |
|
3275
Baytex Energy
BTE
$3.35B
| $195K | ﹤0.01% |
64,700
-36,600
| -36% | -$95.8K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.